File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Clinical utility of direct disk diffusion testing in guiding antibiotic therapy for Gram-negative bacteremia

TitleClinical utility of direct disk diffusion testing in guiding antibiotic therapy for Gram-negative bacteremia
Authors
Issue Date11-Oct-2025
PublisherElsevier
Citation
International Journal of Infectious Diseases, 2025, v. 161 How to Cite?
Abstract

Objective
Conventional antibiotic susceptibility testing (AST) for bloodstream infections requires -48 hours, often delaying optimal therapy. We investigated the clinical impact of implementing direct disk diffusion testing (dDDT) for Gram-negative bacteremia.
Methods
This retrospective cohort study compared patients with Gram-negative bacteremia before (n = 212) and after (n = 214) dDDT implementation. The primary outcome, 30-day mortality, was assessed using the Kaplan-Meier method, a Kolmogorov-Smirnov test, and a multivariate Cox proportional hazards model, with logistic regression for sensitivity analysis. Secondary analyses on therapy appropriateness and the antibiotic spectrum index (ASI) were performed using a mixed-design ANOVA.
Results
dDDT reduced the mean time to susceptibility results by 24 hours (37.6 ± 14.3 hours vs. 61.6 ± 16.3 hours hours). Post-implementation, the appropriateness of therapy for multidrug-resistant organisms (MDROs) significantly improved from 76.5% to 91.2% (P = 0.048). ASI analysis confirmed these changes were driven by appropriate escalation for MDROs and de-escalation for non-MDROs. Kaplan-Meier analysis showed lower cumulative mortality post-dDDT (P = 0.023), but dDDT was not an independent predictor of 30-day mortality in multivariate analysis (aHR 1.27, 95% CI 0.76-2.14).
Conclusions
dDDT implementation significantly shortens time-to-results and improves antibiotic appropriateness, facilitating timely stewardship. While a trend towards lower mortality was observed, dDDT was not an independent predictor of survival, highlighting the multifactorial nature of patient outcomes.
Summary
Direct disk diffusion testing (dDDT) for Gram-negative bacteremia significantly shortens susceptibility reporting, improves antibiotic appropriateness, and may guide antibiotic stewardship. While a trend towards lower mortality was observed, dDDT was not an independent predictor of survival in this study.


Persistent Identifierhttp://hdl.handle.net/10722/366691
ISSN
2023 Impact Factor: 4.8
2023 SCImago Journal Rankings: 1.435

 

DC FieldValueLanguage
dc.contributor.authorChiu, Edwin Kwan-Yeung-
dc.contributor.authorMa, Ting-Fung-
dc.contributor.authorChan, King-Pui Florence-
dc.contributor.authorLi, Xin-
dc.contributor.authorChiu, Kelvin Hei-Yeung-
dc.contributor.authorSo, Simon Yung-Chun-
dc.contributor.authorCheng, Vincent Chi-Chung-
dc.contributor.authorHo, Pak-Leung-
dc.date.accessioned2025-11-25T04:21:16Z-
dc.date.available2025-11-25T04:21:16Z-
dc.date.issued2025-10-11-
dc.identifier.citationInternational Journal of Infectious Diseases, 2025, v. 161-
dc.identifier.issn1201-9712-
dc.identifier.urihttp://hdl.handle.net/10722/366691-
dc.description.abstract<p>Objective<br>Conventional antibiotic susceptibility testing (AST) for bloodstream infections requires -48 hours, often delaying optimal therapy. We investigated the clinical impact of implementing direct disk diffusion testing (dDDT) for Gram-negative bacteremia.<br>Methods<br>This retrospective cohort study compared patients with Gram-negative bacteremia before (n = 212) and after (n = 214) dDDT implementation. The primary outcome, 30-day mortality, was assessed using the Kaplan-Meier method, a Kolmogorov-Smirnov test, and a multivariate Cox proportional hazards model, with logistic regression for sensitivity analysis. Secondary analyses on therapy appropriateness and the antibiotic spectrum index (ASI) were performed using a mixed-design ANOVA.<br>Results<br>dDDT reduced the mean time to susceptibility results by 24 hours (37.6 ± 14.3 hours vs. 61.6 ± 16.3 hours hours). Post-implementation, the appropriateness of therapy for multidrug-resistant organisms (MDROs) significantly improved from 76.5% to 91.2% (P = 0.048). ASI analysis confirmed these changes were driven by appropriate escalation for MDROs and de-escalation for non-MDROs. Kaplan-Meier analysis showed lower cumulative mortality post-dDDT (P = 0.023), but dDDT was not an independent predictor of 30-day mortality in multivariate analysis (aHR 1.27, 95% CI 0.76-2.14).<br>Conclusions<br>dDDT implementation significantly shortens time-to-results and improves antibiotic appropriateness, facilitating timely stewardship. While a trend towards lower mortality was observed, dDDT was not an independent predictor of survival, highlighting the multifactorial nature of patient outcomes.<br>Summary<br>Direct disk diffusion testing (dDDT) for Gram-negative bacteremia significantly shortens susceptibility reporting, improves antibiotic appropriateness, and may guide antibiotic stewardship. While a trend towards lower mortality was observed, dDDT was not an independent predictor of survival in this study.<br></p>-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofInternational Journal of Infectious Diseases-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleClinical utility of direct disk diffusion testing in guiding antibiotic therapy for Gram-negative bacteremia-
dc.typeArticle-
dc.identifier.doi10.1016/j.ijid.2025.108127-
dc.identifier.volume161-
dc.identifier.eissn1878-3511-
dc.identifier.issnl1201-9712-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats